Synapse · 1999 · 14 citations · 36 references
MedicineMolecular BiologyPharmacologyImmunopharmacologyMolecular PharmacologyPharmacodynamicsDrug-receptor InteractionsLigand BindingLigand-receptor InteractionsReceptor BindingReceptor PharmacologyReceptor-ligand InteractionsEndogenous OpioidsOpioid Receptor BindingOrphan ReceptorsSelectivity
Western blots using an antibody which recognizes the orphanin FQ/nociceptin (OFQ/N) receptor reveals a band at approximately 69 kD in several cell lines, including the Raji human B cell lymphoma cell line. RT-PCR confirms the presence of this receptor in the Raji cells. Binding studies revealed a high affinity [(125)I][Tyr(14)]OFQ/N site in the Raji cells. The affinity of [(125)I][Tyr(14)]OFQ/N in the Raji cells (K(D) 68.4 pM) was similar to that in the transfected receptor (K(D) 36.7 pM). Its selectivity profile also was quite similar. OFQ/N competed binding quite potently (K(i) 65 pM), as did [Tyr(14)]OFQ/N (K(i) 33 pM). Traditional opioids displayed no appreciable affinity for the binding at any concentration examined, with the exception of naloxone benzoylhydrazone, which had only a very modest affinity. The receptors in the Raji cells were functionally active. OFQ/N inhibited forskolin-stimulated cyclase by 72% with an IC(50) value of approximately 1 nM.
36
Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor
Jean‐Claude Meunier, Catherine Mollereau, Lawrence Toll et al. · Nature · 1995 · 1.9K citations
Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled Receptor
Rainer K. Reinscheid, Hans‐Peter Nothacker, Anne Bourson et al. · Science · 1995 · 1.8K citations
Medicine, Neuroscience, Pharmacology +17
ORL1, a novel member of the opioid receptor family
Catherine Mollereau, Marc Parmentier, Pierre Mailleux et al. · FEBS Letters · 1994 · 1.1K citations